Knudson Jeffrey R
Known title: CFO/CAOCIK: 0001752946
Knudson Jeffrey R's purchase track record
Knudson Jeffrey R has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 2/28/2024 | AMN | $401K | -3.3% | -5.1% | +10.3% |
| 3/11/2022 | AMN | $500K | +6.9% | +13.1% | -3.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| AMN | ▼ Sell | Open Market | 2,461 | $91K | 11/2/2024 | View on chart |
| AMN | ▲ Buy | Option Exercise | 9,950 | $0 | 11/2/2024 | View on chart |
| AMN | ▲ Buy | Option Exercise | 2,232 | $0 | 10/15/2024 | View on chart |
| AMN | ▼ Sell | Tax Withholding | 544 | $22K | 10/15/2024 | View on chart |
| AMN | ▲ Buy | Open Market | 6,951 | $401K | 2/28/2024 | View on chart |
| AMN | ▲ Buy | Option Exercise | 1,890 | $0 | 1/15/2024 | View on chart |
| AMN | ▼ Sell | Tax Withholding | 491 | $38K | 1/15/2024 | View on chart |
| AMN | ▲ Buy | Option Exercise | 1,599 | $0 | 1/15/2024 | View on chart |
| AMN | ▼ Sell | Tax Withholding | 475 | $37K | 1/15/2024 | View on chart |
| AMN | ▲ Buy | Option Exercise | 9,656 | $0 | 11/2/2023 | View on chart |
| AMN | ▼ Sell | Tax Withholding | 3,800 | $291K | 11/2/2023 | View on chart |
| AMN | ▲ Buy | Option Exercise | 1,141 | $0 | 1/15/2023 | View on chart |
| AMN | ▼ Sell | Tax Withholding | 457 | $47K | 1/15/2023 | View on chart |
| AMN | ▲ Buy | Option Exercise | 9,656 | $0 | 11/2/2022 | View on chart |
| AMN | ▼ Sell | Tax Withholding | 3,683 | $468K | 11/2/2022 | View on chart |
| AMN | ▲ Buy | Open Market | 5,349 | $499K | 3/11/2022 | View on chart |
| AMN | ▲ Buy | Open Market | 11 | $1K | 3/11/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
AMN Healthcare Maintains Outperform Rating, Target Raised to $43
Analyst BMO Capital kept an Outperform rating on AMN Healthcare and increased its price target to $43. The company announced a third‑quarter 2026 earnings conference call scheduled for November 5. The stock trades near its $33.96 support level and carries a trailing P/E of 13.4, while analysts’ average target is $36.14.
AMN Healthcare Maintains Outperform Rating, Target Raised to $43. Analyst BMO Capital kept an Outperform rating on AMN Healthcare and increased its price target to $43. The company announced a third‑quarter 2026 earnings conference call scheduled for November 5. The stock trades near its $33.96 support level and carries a trailing P/E of 13.4, while analysts’ average target is $36.14.